At a glance
- Originator Farmak International
- Class Anti-inflammatories; Heterocyclic compounds
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Influenza A virus infections
Most Recent Events
- 04 Sep 2015 No recent reports on development identified - Phase-II for Influenza-A virus infections in Austria, Germany (PO)